Biomedica Immunoassays

#BigEndothelin #heartfailure #coronaryarterydisease #biomarkerELISA #fullyvalidatedforclinicalresearch

Big Endothelin-1 (BigET-1) is a vasoconstrictive peptide that plays a key role in the development of #heartfailure. Our BigET-1 ELISA #assay was successfully used in a large cohort study of nearly 8000 prediabetic and diabetic patients with stable Coronary Artery Disease (CAD). Key highlights: 🔹 Plasma BigET-1 level is an independent predictor of #cardiovascular events (CVEs) in patients with stable CAD. 🔹 BigET-1 remains independently associated with worse cardiovascular outcomes in prediabetic and diabetic patients but not in patients with normoglycemia. 🔹 Patients with diabetes and high Big #Endothelin-1 levels were associated with the highest risk of CVEs in patients with stable CAD. Find out more in the comments below 👇 #biomedica #biomedicaimmunoassays #diabetes #prediction #coronaryarterydisease #biomarkers

Exciting research update! We are proud to share that our Vanin-1 ELISA was featured in a recent study investigating the relationship between urinary Vanin-1 (uVNN-1) as a marker of #kidneydisease and peripheral artery disease (PAD) severity. Key findings: • uVNN-1 levels are an independent link to both all-cause and #cardiovascular mortality in patients with PAD. • uVNN1 concentrations were associated with early kidney disease. • Vanin-1 may serve as a practical marker for #riskstratification of kidney disease in PAD. Find out more via the 🔗 link in the comments below 👇 #biomedica #biomedicaimmunoassays #CKD #fibrosis #inflammation #peripheralarterydisease #biomarkers

#DiabetesAwarenessMonth #boneloss #Sclerostin #biomarkerELISA #fullyvalidatedforclinicalresearch

November is #DiabetesAwarenessMonth. One severe complication of diabetes is #boneloss potentially resulting in #osteoporosis and increased fracture risk. Identifying #biomarkers that may predict fracture risk in individuals with diabetes is crucial for improving patient care. The bone-related protein #Sclerostin has emerged as a promising circulating marker of diabetic bone disease. 🔹 Learn more and follow the link in the comment below 👇 #biomedica #biomedicaimmunoassays #diabetes #bonehealth #fracturerisk #biomarker

#IL6 #inflammation #cytokines #biomarkerELISA #fullyvalidatedforclinicalresearch

Discover our highly sensitive human Interleukin-6 (IL-6) ELISA Kit: • SENSITIVE – detectable values in serum and plasma samples! • STANDARDIZED – kit calibration using WHO standards • QUALITY – validated according to international guidelines • EASY – ready to use color coded, prediluted standards & controls 👇🏻 Check out our end of the year IL-6 #ELISA 🎉 campaign in the link below #biomedica #biomedicaimmunoassays #immunology #inflammation #cytokines #IL-6

Exciting research update on novel biomarkers for sepsis! Our soluble #Neuropilin-1 (sNRP-1) ELISA assay was featured in a 2024 study investigating the role of sNRP-1 in #criticalillness and sepsis and assesses its potential as a #biomarker in this setting. Key findings: 🔹 Critically ill and septic patients exhibit higher levels of circulating sNRP-1. 🔹 sNRP-1 levels correlate with organ failure, particularly hepatic and kidney function impairment. 🔹 Long-term survivors have lower levels of sNRP-1 upon admission to the ICU. Biomedica´s Total Soluble Neuropilin-1 ELISA Kit is the only assay that detects free and ligand-bound soluble Neuropilin-1! Find out more via the link in the comments below #biomedica #biomedicaimmunoassays #inflammation #intensivecareunit #sepsis #biomarker #clinicalresearch

We´re proud to share that our bone #biomarker assays (Sclerostin, Osteoprotegerin, RANKL, DKK-1) were highlighted in a recent study investigating alternations in regulators of the renal-bone axis, #inflammation and #iron status in older people with early renal impairment and the effect of #vitaminD supplementation. The study identified changes in the renal bone-axis that occur BEFORE patients are clinically monitored. #Diagnosis in the early stages of renal impairment may provide opportunities for the #prevention and progression of #renaldisease and chronic kidney disease-mineral bone disorder (CKD-MBD). Find out more via the link in the comments below 👇🏻 BIOMEDICA Quality ELISA assay kits for affordable & efficient research: SOST, OPG, soluble RANKL, DKK-1, FGF23, IL-6 ... ⮞ TRUSTED - cited in over 1000 publications ⮞ Rigorous validation following international quality guidelines ⮞ Kits include 7 ready to use standards and controls ⮞ All assays are developed & manufactured by Biomedica #biomedica #biomedicaimmunoassays #renalimpairment #bone #FGF23 #Sclerostin

Breast cancer is the most common cancer in women worldwide. Improving our understanding of how breast cancer originates, grows and spreads may help to reduce the risk and burden of the #disease. Circulating proteins from serum or plasma can serve as biomarkers for cancer progression and #prognosis and represent prospective #therapeutictargets. Ongoing research has highlighted PERIOSTIN, NEUROPILIN-1, SEMAPHORIN 4D, and LRG-1 as promising protein biomarkers in breast cancer and potential treatment targets. These proteins can easily be detected in human serum and plasma by ELISA #assay. Learn more about novel biomarkers in breast #cancer and discover our reliable #ELISA Kits for #cancerresearch via the link in the comments ⬇️ #biomedica #biomedicaimmunoassays #breastcancer #biomarkers #research #personalizedmedicine